We are live on
!
Find out more
ACM
Aster Capital Management Portfolio holdings
AUM
$306M
1-Year Est. Return
18%
This Fund
S&P 500
This Quarter
Est. Return
+2.89%
1 Year Est. Return
+18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$228M
AUM Growth
+$30.4M
(+15%)
Cap. Flow
+$30.3M
Cap. Flow
% of AUM
13.29%
Top 10 Holdings %
Top 10 Hldgs %
31.68%
Holding
1,487
New
557
Increased
199
Reduced
298
Closed
433
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$15.8M |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.32M |
| 3 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$8.76M |
| 4 |
Walmart Inc
WMT
|
+$7.84M |
| 5 |
Apple
AAPL
|
+$5.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.18M |
| 2 |
Abbott
ABT
|
+$2.92M |
| 3 |
HCA Healthcare
HCA
|
+$2.86M |
| 4 |
Wells Fargo
WFC
|
+$2.72M |
| 5 |
Bank of America
BAC
|
+$2.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.46% |
| 2 | Financials | 12.13% |
| 3 | Industrials | 10.93% |
| 4 | Healthcare | 10.36% |
| 5 | Consumer Staples | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCW
826
DELISTED
Mister Car Wash
MCW
| $6.5K | ﹤0.01% |
+1,169
| New | +$6.15K |
|
827
Ocular Therapeutix
OCUL
$1.87B
| $6.5K | ﹤0.01% |
+535
| New | +$6.5K |
|
828
Oneok
OKE
$55B
| $6.47K | ﹤0.01% |
88
-2,446
| -97% | -$173K |
|
829
Astrana Health
ASTH
$1.78B
| $6.43K | ﹤0.01% |
259
+72
| +39% | +$1.91K |
|
830
Madrigal Pharmaceuticals
MDGL
$11.9B
| $6.41K | ﹤0.01% |
11
-74
| -87% | -$37.8K |
|
831
Kiniksa Pharmaceuticals
KNSA
$6.09B
| $6.39K | ﹤0.01% |
+155
| New | +$6.22K |
|
832
Triumph Financial Inc
TFIN
$1.87B
| $6.39K | ﹤0.01% |
+102
| New | +$5.71K |
|
833
GeneDx Holdings
WGS
$2.08B
| $6.37K | ﹤0.01% |
+49
| New | +$6.72K |
|
834
Kennametal
KMT
$2.6B
| $6.31K | ﹤0.01% |
+222
| New | +$5.67K |
|
835
Williams-Sonoma
WSM
$29.2B
| $6.25K | ﹤0.01% |
+35
| New | +$6.56K |
|
836
Corcept Therapeutics
CORT
$12B
| $6.16K | ﹤0.01% |
+177
| New | +$13.9K |
|
837
Ecovyst
ECVT
$1.25B
| $6.13K | ﹤0.01% |
630
+251
| +66% | +$2.19K |
|
|
ARI
838
Apollo Commercial Real Estate
ARI
$872M
| $6.13K | ﹤0.01% |
+633
| New | +$6.33K |
|
839
Seneca Foods Class A
SENEA
$1.16B
| $6.08K | ﹤0.01% |
+55
| New | +$6.29K |
|
|
DAWN
840
DELISTED
Day One Biopharmaceuticals
DAWN
| $6.07K | ﹤0.01% |
+651
| New | +$5.44K |
|
841
AnaptysBio
ANAB
$1.63B
| $6.06K | ﹤0.01% |
+125
| New | +$4.87K |
|
842
Azenta
AZTA
$1.47B
| $6.05K | ﹤0.01% |
+182
| New | +$5.95K |
|
|
NPKI
843
NPK International
NPKI
$1.15B
| $6.03K | ﹤0.01% |
506
-358
| -41% | -$4.37K |
|
|
CURB
844
Curbline Properties
CURB
$3.46B
| $5.99K | ﹤0.01% |
+258
| New | +$6.01K |
|
845
First Financial Bancorp
FFBC
$3.61B
| $5.93K | ﹤0.01% |
+237
| New | +$5.92K |
|
846
Castle Biosciences
CSTL
$929M
| $5.87K | ﹤0.01% |
+151
| New | +$4.87K |
|
847
Lifestance Health
LFST
$3.96B
| $5.87K | ﹤0.01% |
834
+15
| +2% | +$91 |
|
|
KW
848
DELISTED
Kennedy-Wilson Holdings
KW
| $5.83K | ﹤0.01% |
+603
| New | +$5.41K |
|
|
BBUC
849
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.33B
| $5.81K | ﹤0.01% |
162
-149
| -48% | -$5.22K |
|
850
Silicon Laboratories
SLAB
$7.2B
| $5.75K | ﹤0.01% |
+44
| New | +$5.79K |
|
Similar funds
RFM
FAM
IPGDR
SIM
MWA
HKIM
BICM
TFA
Aster Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Aster Capital Management held 1,487 positions worth $228M, up 15% from $198M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Aster Capital Management deployed $30.3M of net new capital in Q4 2025, opening 557 new positions and adding to 199 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Pultegroup, an estimated $1.87M trimmed.
- Aster Capital Management's largest Q4 2025 buy was Invesco S&P 500 Equal Weight ETF: 49,113 shares worth $9.41M.
- Aster Capital Management added most to Broadcom in Q4 2025, an estimated $15.8M increase.
- Aster Capital Management's biggest Q4 2025 reduction was Pultegroup, cutting an estimated $1.87M.
- Aster Capital Management fully exited Johnson & Johnson in Q4 2025, selling an estimated $4.18M.
- Aster Capital Management's ten largest holdings make up 32% of its $228M portfolio in Q4 2025.
- Aster Capital Management opened 557 new positions and closed 433 in Q4 2025.
- Aster Capital Management's portfolio value rose 15% quarter-over-quarter to $228M.
Based on Aster Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.